Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Sharkey

Showing results (81-90 of 145) with videos related to

Pageof 15
Sort By:
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
Sacral scintigraphy for bone marrow dosimetry in radioimmunotherapyJ A Siegel, R E Lee, D A Pawlyk, et al.
Biophysical Journal|May 12, 2009
Structure and functional reconstitution of the sodium channel from rat brainJ A Talvenheimo, M M Tamkun, D J Messner, et al.
Gynecologic Oncology|January 27, 1998
Prospects of radioimmunotherapy in epithelial ovarian cancer: results with iodine-131-labeled murine and humanized MN-14 anti-carcinoembryonic antigen monoclonal antibodiesM Juweid, L C Swayne, R M Sharkey, et al.
Cancer Research|March 15, 1991
Galactose-conjugated antibodies in cancer therapy: properties and principles of actionG L Ong, D Ettenson, R M Sharkey, et al.
Journal of the National Cancer Institute|May 1, 1991
Successful radioimmunotherapy for lung metastasis of human colonic cancer in nude miceR M Sharkey, K S Weadock, A Natale, et al.
Cancer|June 1, 1978
Carcinoembryonic antigen in ovarian epithelial cystadenocarcinomas: the prognostic value of tumor and serial plasma determinationsJ R van Nagell, E S Donaldson, E C Gay, et al.
Bioconjugate Chemistry|November 23, 2000
Experimental pretargeting studies of cancer with a humanized anti-CEA x murine anti-[In-DTPA] bispecific antibody construct and a (99m)Tc-/(188)Re-labeled peptideH Karacay, W J McBride, G L Griffiths, et al.
Cancer|December 24, 1997
Factors influencing hematologic toxicity of radioimmunotherapy with 131I-labeled anti-carcinoembryonic antigen antibodiesM E Juweid, C H Zhang, R D Blumenthal, et al.
International Journal of Cancer|May 2, 1997
The advantage of residualizing radiolabels for targeting B-cell lymphomas with a radiolabeled anti-CD22 monoclonal antibodyM J Mattes, L B Shih, S V Govindan, et al.
Cancer Research|May 1, 1990
Murine monoclonal antibodies against carcinoembryonic antigen: immunological, pharmacokinetic, and targeting properties in humansR M Sharkey, D M Goldenberg, H Goldenberg, et al.
Pageof 15

Showing results (81-90 of 145) with videos related to

Sort By:
Pageof 15
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
Sacral scintigraphy for bone marrow dosimetry in radioimmunotherapyJ A Siegel, R E Lee, D A Pawlyk, et al.
Biophysical Journal|May 12, 2009
Structure and functional reconstitution of the sodium channel from rat brainJ A Talvenheimo, M M Tamkun, D J Messner, et al.
Gynecologic Oncology|January 27, 1998
Prospects of radioimmunotherapy in epithelial ovarian cancer: results with iodine-131-labeled murine and humanized MN-14 anti-carcinoembryonic antigen monoclonal antibodiesM Juweid, L C Swayne, R M Sharkey, et al.
Cancer Research|March 15, 1991
Galactose-conjugated antibodies in cancer therapy: properties and principles of actionG L Ong, D Ettenson, R M Sharkey, et al.
Journal of the National Cancer Institute|May 1, 1991
Successful radioimmunotherapy for lung metastasis of human colonic cancer in nude miceR M Sharkey, K S Weadock, A Natale, et al.
Cancer|June 1, 1978
Carcinoembryonic antigen in ovarian epithelial cystadenocarcinomas: the prognostic value of tumor and serial plasma determinationsJ R van Nagell, E S Donaldson, E C Gay, et al.
Bioconjugate Chemistry|November 23, 2000
Experimental pretargeting studies of cancer with a humanized anti-CEA x murine anti-[In-DTPA] bispecific antibody construct and a (99m)Tc-/(188)Re-labeled peptideH Karacay, W J McBride, G L Griffiths, et al.
Cancer|December 24, 1997
Factors influencing hematologic toxicity of radioimmunotherapy with 131I-labeled anti-carcinoembryonic antigen antibodiesM E Juweid, C H Zhang, R D Blumenthal, et al.
International Journal of Cancer|May 2, 1997
The advantage of residualizing radiolabels for targeting B-cell lymphomas with a radiolabeled anti-CD22 monoclonal antibodyM J Mattes, L B Shih, S V Govindan, et al.
Cancer Research|May 1, 1990
Murine monoclonal antibodies against carcinoembryonic antigen: immunological, pharmacokinetic, and targeting properties in humansR M Sharkey, D M Goldenberg, H Goldenberg, et al.
Pageof 15